By rpm
TenNor Therapeutics Announces $25 Million Series B Financing to Advance TNP-2092 Clinical Trials2016-09-192016-09-21http://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.pngRedPepper Mergershttp://redpeppermergers.com/wp-content/uploads/rpm-white-red-1.png200px200px